Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Aspen Pharma Trading Limited 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
Zyloric 100 mg Tablets.
Zyloric 300 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Each 100 mg tablet is round, white to off-white, biconvex, bisected tablet, debossed with Z1 on one side. Each 300 mg tablet is round, white to off-white, biconvex, bisected tablet, debossed with Z3 on one side. The score line is only to facilitate breaking for ease of swallowing and not to divide the tablet into equal doses. |
Allopurinol 100 mg (Zyloric Tablets).
Allopurinol 300 mg (Zyloric-300 Tablets).
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Allopurinol is a xanthine-oxidase inhibitor. Allopurinol and its main metabolite oxipurinol lower the level of uric acid in plasma and urine by inhibition of xanthine oxidase, the enzyme catalyzing the oxidation of hypoxanthine to xanthine and xanthine to uric acid. |
| List of Excipients |
|---|
|
Lactose |
Zyloric 100 mg Tablets: PVC/aluminium foil blister packs of 100 tablets.
Zyloric-300 Tablets: PVC/aluminium foil blister packs (2 strips of 14 tablets).
Aspen Pharma Trading Limited 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
PL 39699/0001 – Zyloric 100 mg Tablets
PL 39699/0002 – Zyloric-300 Tablets
Zyloric 100 mg Tablets:
Date of first authorisation: 20.03.80
Renewal: 06.06.90
Date of latest renewal: 14.11.95
Zyloric-300 Tablets:
Date of first authorisation: 14.07.80
Renewal: 18.02.91
Date of latest renewal: 25.11.98
| Drug | Countries | |
|---|---|---|
| ZYLORIC | Austria, Brazil, Cyprus, Spain, France, Hong Kong, Ireland, Italy, Japan, Malta, Netherlands, Singapore, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.